Furthermore, functional nanoparticles based on DQA were developed for targeted delivery of classical cytotoxic anticancer drugs (such as doxorubicin) to tumor cells, which showed significant anticancer efficacy in a drug-resistant tumor model via triggering cytochrome c release and mitochondrial apoptosis [546]. This evidence concerns the gene CYCS and neoplasm.